GRAMMER ELIZABETH A 4
4 · Sagimet Biosciences Inc. · Filed Jun 7, 2024
Insider Transaction Report
Form 4
GRAMMER ELIZABETH A
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-05+51,459→ 51,459 totalExercise: $4.64Exp: 2034-06-04→ Series A Common Stock (51,459 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 5, 2024, subject to the Reporting Person's continued service on each such vesting date.